HK Stock Market Move | YUNJI-NEW(02670) Opens Over 4% Higher; 1,000-Unit Siasun Robot&Automation Order Has Entered Continuous Delivery Phase; Management Members Voluntarily Extend Lock-Up Commitment
YUNJI-NEW(02670) opened over 4% higher. As of press time, it was up 4.03% at HK$3.225, with a turnover of HK$551,500.
YUNJI-NEW(02670) opened over 4% higher, up 4.03% as of press time at HK$3.225, with a turnover of HK$551,500.
On the news front, YUNJI-NEW announced that in the first nine months of 2026, the Group's Siasun Robot&Automation operations maintained steady growth, with products cumulatively covering more than 45,000 hotels. Hotel group customers continued to expand HDOS applications. On the ecosystem partner front, the Group's order for 1,000 Siasun Robot&Automation units in cooperation with Wild Bird has entered the continuous delivery phase; the Runyi project order involving 100 Siasun Robot&Automation units has begun deployment in multiple hospitals. The Group has signed another strategic cooperation agreement with an ecosystem partner involving 2,000 Siasun Robot&Automation units, with the relevant Siasun Robot&Automation units planned for delivery in 2027, subject to the final agreement for specific cooperation and delivery arrangements.
It is worth noting that YUNJI-NEW recently announced that Ms. Zhi Tao (Ms. Zhi) and Mr. Li Quanyin (Mr. Li) have voluntarily made lock-up commitments. Ms. Zhi is the chairman, executive director and president of the Company; Mr. Li is the executive director and chief executive officer of the Company. Ms. Zhi and Mr. Li have each voluntarily committed to extending the lock-up period for shares directly held by them to October 15, 2027.
Related Articles

Allergy and autoimmune biotech company Lycia Therapeutics (LYCA.US) is set to list on Nasdaq tonight! IPO priced at $18 per share, aiming to raise $317.5 million.

HK Stock Market Move | MAO GEPING (01318) rises over 5%, as the Double 11 promotion continues to catalyze, and the company's September GMV growth rate accelerates.

Citi: CGN POWER (01816) 2027 Earnings Growth Expected to Be Driven by Potential Guangdong Power Price Increases
Allergy and autoimmune biotech company Lycia Therapeutics (LYCA.US) is set to list on Nasdaq tonight! IPO priced at $18 per share, aiming to raise $317.5 million.

HK Stock Market Move | MAO GEPING (01318) rises over 5%, as the Double 11 promotion continues to catalyze, and the company's September GMV growth rate accelerates.

Citi: CGN POWER (01816) 2027 Earnings Growth Expected to Be Driven by Potential Guangdong Power Price Increases






